Pluri Inc. Logo

Pluri Inc.

Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.

PLUR | TA

Overview

Corporate Details

ISIN(s):
US72942G2030
LEI:
Country:
Israel
Address:
Park Building No. 5, 3508409 Haifa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Pluri Inc., formerly Pluristem Therapeutics, is a biotechnology company that researches, develops, and manufactures cell-based products and therapeutics. The company specializes in its proprietary 3D cell-expansion technology platform, which is used to create solutions for commercial use aimed at improving human well-being and sustainability. Pluri develops products from placenta-based cells for applications across the medical and pharmaceutical industries, often in collaboration with research partners and academic institutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-23 17:54
Director's Dealing
Other Report or Announcement
English 152.3 KB
2025-09-23 17:54
Foreign Filer Report
Other Report or Announcement
English 36.5 KB
2025-09-18 03:08
Registration Form
Other Report or Announcement
English 729.3 KB
2025-09-18 03:08
Foreign Filer Report
Other Report or Announcement
English 36.4 KB
2025-09-18 02:33
Registration Form
Other Report or Announcement
English 315.7 KB
2025-09-18 02:33
Registration Form
Other Report or Announcement
English 36.4 KB
2025-09-18 02:31
Registration Form
Other Report or Announcement
English 317.6 KB
2025-09-18 02:31
Foreign Filer Report
Other Report or Announcement
English 36.4 KB
2025-09-18 01:48
Annual Report
Report of Periodic or Interim Report
English 4.1 MB
2025-09-18 01:48
Foreign Filer Report
Report of Periodic or Interim Report
English 36.7 KB
2025-09-12 17:10
Board/Management Information
Immediate Report
English 112.9 KB
2025-09-12 17:10
Foreign Filer Report
Immediate Report
English 36.5 KB
2025-09-11 17:10
Board/Management Information
The board of directors elected Mr. Eitan Ajchenbaum to serve as a member of the…
English 117.2 KB
2025-09-11 17:10
Foreign Filer Report
The board of directors elected Mr. Eitan Ajchenbaum to serve as a member of the…
English 36.5 KB
2025-07-03 22:43
Post-Annual General Meeting Information
Immediate Report
Hebrew (modern) 224.6 KB

Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Pluri Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.